Acute Bronchitis: Clinical Trials

43 trials for Acute Bronchitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 7 unknown, 3 recruiting, 2 enrolling by invitation. 13 Phase 3, 9 Phase 4, 8 Not applicable, 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 313Completed 9, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 49Completed 5, Unknown 2, Enrolling by invitation 1, Recruiting 1
Not applicable8Completed 5, Enrolling by invitation 1, Recruiting 1, Unknown 1
Phase 26Completed 5, Unknown 1
Phase 11Completed 1

Follow Acute Bronchitis: new trials by email Literature Review of Acute Bronchitis trials Research Report on Acute Bronchitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.
DSP2505(Canium), Umckamin, Placebo Matching Umckamin - Acute Bronchitis
Phase 4CompletedDasan Pharmaceutical Co., Ltd.2232026-01-262026-09-23
Improving Patient-centered Communication and Antibiotic Use With Information Sheets for Acute Respiratory Tract Infections: A Study Protocol
ARTI Info-sheets - Acute Bronchitis, ACUTE SINUSITIS
Not applicableEnrolling by invitationResearch Unit for General Practice in Aalborg11442026-01-052026-02-03
Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients
Raphamin, Placebo - Bronchitis, Acute Bronchitis
Phase 3RecruitingMateria Medica Holding3082025-12-092026-06-29
Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care
Antibiotic prescribing according to guidelines - Angina, Acute Bronchiolitis
Not applicableRecruitingUniversity Hospital, Caen45002025-12-012026-01-22
Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
AG2001, AG20011, AG20012 - Acute Bronchitis
Phase 3Not yet recruitingAhn-Gook Pharmaceuticals Co.,Ltd3002025-11-012025-09-30
Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
YHP2401, YHR2402, YHR2403 - Acute Bronchitis
Phase 3CompletedYuhan Corporation2862025-08-192026-02-09
Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients
Elixirium thymi compositum (FoNo VIII.), Elixirium thymi compositum (FoNo VIII.) placebo - Acute Bronchitis
Phase 4Enrolling by invitationSemmelweis University562025-07-012025-06-26
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
ALC-2203-1, ALC-2203-2, ALC-2203-AC - Acute Bronchitis
Phase 2CompletedKorea Arlico Pharm. Co., Ltd1692025-04-232025-12-24
Phase 1 Study to Evaluate the Safety and Drug-Drug Interactions in Healthy Adult Participants
AG2203L, AG2203E, AG2203L+AG2203E - Acute Bronchitis
Phase 1CompletedAhn-Gook Pharmaceuticals Co.,Ltd362025-03-282026-09-01
A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212
DW5121, DW51211, DW51212 - Acute Bronchitis
Phase 3CompletedDaewon Pharmaceutical Co., Ltd.2732024-03-282025-07-30
Treatment of Adults With Acute Bronchitis in the Primary Healthcare Setting
Atusin CAP, Placebo - Acute Bronchitis
Not applicableCompletedNeopharm Bulgaria Ltd.3102024-01-302024-10-30
The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients
Atock Dry Syrup with placebo patch, Tulobuterol patch with placebo dry syrup - Acute Bronchitis
Phase 4RecruitingSamA Pharmaceutical Co., Ltd2962023-11-102025-09-23
Evaluating the Potential of Large Language Models for Respiratory Disease Consultations
Diagnosis by three human doctors, Diagnosis by ChatGPT-3.5 (with search capabilities), Diagnosis by ChatGPT-3.5 (without search capabilities) - Hay Fever, Asthma
Not applicableCompletedNorth Sichuan Medical College7032023-10-012024-11-27
Management of Acute Bronchitis With Pelargonium Sidoides Extract
Pelargonium sidoides extract EPs® 7630, usual care - Acute Bronchitis
Not applicableCompletedUniversity of Fribourg3322023-05-152026-01-16
Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule
Bronpass Tab., Placebo of Erdos capsule, Erdos capsule - Acute Bronchitis
Phase 4CompletedKwang-Ha Yoo1102022-04-152023-09-14
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
Diagnostic Test: Sputum DNA methylation analysis, chest CT or pathological examination - Lung Cancer, Small Cell Lung Cancer
CompletedCreative Biosciences (Guangzhou) Co., Ltd.15642022-02-252025-03-21
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Exposure of interest (studies 2 & 3). - Alopecia Areata, Depressive Episode
CompletedMomentum Data519552020-10-012022-12-15
A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis
AGS (Experimental), AGU (Active Comparator) - Acute Bronchitis
Phase 3CompletedAhn-Gook Pharmaceuticals Co.,Ltd2202019-10-172022-04-25
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis
GHX02, Placebo - Acute Bronchitis
Phase 2UnknownDaejeon University1502019-03-182019-03-05
Effectiveness of Antitussives, Anticholinergics and Honey Versus Usual Care in Adults With Acute Bronchitis.
Dextromethorphan 15 milligrams, Ipratropium Bromide 20Micrograms Inhaler, Honey 30 g (full tablespoon) - Acute Bronchitis
Phase 4CompletedFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina6682019-02-012022-08-30

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Bronchitis (43)  ·  Respiratory Tract Infections (7)  ·  Pneumonia (5)  ·  Cough (4)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Influenza, Human (3)  ·  Lung Neoplasms (3)  ·  Pharyngitis (3)  ·  Tuberculosis (3)  ·  Asthma (2)  ·  Bronchiectasis (2)  ·  Bronchitis, Chronic (2)  ·  Community-Acquired Pneumonia (2)  ·  Otitis Media (2)  ·  Personal Satisfaction (2)

Broader conditions

Bronchial Diseases (43)  ·  Lung Diseases (43)  ·  Lung Diseases, Obstructive (43)  ·  Respiratory Tract Diseases (43)  ·  Infections (42)  ·  Respiratory Tract Infections (36)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Pathologic Processes (8)  ·  Otorhinolaryngologic Diseases (7)  ·  Disease Attributes (6)  ·  Signs and Symptoms (6)  ·  Chronic Disease (5)  ·  Nose Diseases (5)  ·  Signs and Symptoms, Respiratory (5)  ·  Stomatognathic Diseases (5)

Interventions

Antimicrobial Stewardship (1)  ·  Antitussive Agents (1)  ·  Aspartylglucosylaminase (1)  ·  Bronchoscopy (1)  ·  Cholecalciferol (1)  ·  Cholinergic Antagonists (1)  ·  Dietary Supplements (1)  ·  Honey (1)  ·  Streptodornase and Streptokinase (1)  ·  Theobromine (1)  ·  X-Rays (1)  ·  ambroxol-theophylline-7-acetate (1)  ·  andrographolide sulfonate (1)  ·  dipropizine (1)  ·  microcrystalline cellulose (1)

Sponsors

Ahn-Gook Pharmaceuticals Co.,Ltd (4)  ·  Hanlim Pharm. Co., Ltd. (3)  ·  Daewon Pharmaceutical Co., Ltd. (2)  ·  SamA Pharmaceutical Co., Ltd (2)  ·  Yuhan Corporation (2)  ·  Asociacion Colaboracion Cochrane Iberoamericana (1)  ·  Creative Biosciences (Guangzhou) Co., Ltd. (1)  ·  Daejeon University (1)  ·  Dasan Pharmaceutical Co., Ltd. (1)  ·  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Hallym University Medical Center (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Hyundai Pharmaceutical Co., LTD. (1)

Countries

South Korea (18)  ·  Spain (4)  ·  China (3)  ·  Bulgaria (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Kazakhstan (1)  ·  Russia (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Pablo Alonso Coello, PhD (2)  ·  Almagul Kushugulova, MD, PhD (1)  ·  Ana Moragas, MD PhD (1)  ·  Andrew McGovern, MD (1)  ·  Antonio Moreno, MD, PhD (1)  ·  Diana Petkova, Prof, PhD (1)  ·  Jae Yeol Kim, M.D. (1)  ·  Jaejeong Shim, Principal Investigator (1)  ·  Jiebin Xie, Doctor (1)  ·  Jun Li (1)  ·  Kabir Yadav, MDCM MS MSHS (1)  ·  Ki-Suck Jung, M.D. (1)  ·  Ki-Suck Jung, MD, PhD (1)  ·  Kwan Ho Lee, M.D. (1)

Results publications

PMID 23682979, PMID 26719947, PMID 29301924, PMID 29764875, PMID 30744616, PMID 31101700, PMID 31515828, PMID 34348724, PMID 34525972, PMID 34785540, PMID 35157313, PMID 36239199, PMID 37784098, PMID 41034950, PMID 41764365

NIH funding

2023 (1), 2025 (1), UL1TR001881 (1)